Variant Guillain–Barre Syndrome Following SARS-CoV-2 Vaccination: Case Report and Review of the Literature
Open Access
- 11 March 2022
- journal article
- letter
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 50 (1) , 138-140
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical TrialNeurology, 2021
- Guillain Barre Syndrome as a Complication of COVID-19: A Systematic ReviewCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2021
- Guillain–Barré Syndrome Associated with SARS-CoV-2New England Journal of Medicine, 2020
- Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteriaClinical Neurology and Neurosurgery, 2017
- Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyThe Lancet, 2016
- Epidemiology ofCampylobacter jejuniIsolated from Patients with Guillain-Barré and Fisher Syndromes in JapanJournal of Clinical Microbiology, 2005
- Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndromeProceedings of the National Academy of Sciences, 2004
- Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroupsActa Neurologica Scandinavica, 2001
- The spectrum of antecedent infections in Guillain-Barré syndromeNeurology, 1998